Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference

Rhea-AI Summary

Sensei Biotherapeutics (Nasdaq: SNSE) announced its participation in Citi's 2024 Global Healthcare Conference. The conference will take place from December 3-5 in Miami, FL. As a clinical stage biotechnology company specializing in next-generation cancer therapeutics, Sensei's management team will be present at this significant healthcare industry event.

News Market Reaction – SNSE

-2.57%

-2.57% Session move

In the trading session that priced this news, SNSE declined 2.57%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that Company management will participate in Citi’s 2024 Global Healthcare Conference, being held on December 3-5, in Miami, FL.

About Sensei Biotherapeutics  
Sensei Biotherapeutics (Nasdaq: SNSE) is a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients. Through its TMAb™ (Tumor Microenvironment Activated biologics) platform, Sensei develops conditionally active therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment to unleash T cells against tumors. Sensei’s lead product candidate is SNS-101, a conditionally active antibody designed to block the V-domain Ig suppressor of T cell activation (VISTA) checkpoint selectively within the low pH tumor microenvironment, where VISTA acts as a suppressor of T cells by binding the receptor PSGL-1. For more information, please visit www.senseibio.com, and follow the company on X @SenseiBio and LinkedIn.

Investor Contact:
Michael Biega
Senior Director, Investor Relations
Sensei Biotherapeutics
mbiega@senseibio.com

Media Contact:
Joyce Allaire
LifeSci Advisors
Jallaire@lifesciadvisors.com

FAQ

When is Sensei Biotherapeutics (SNSE) participating in Citi's 2024 Global Healthcare Conference?

Sensei Biotherapeutics will participate in Citi's 2024 Global Healthcare Conference from December 3-5, 2024, in Miami, FL.

Where will Citi's 2024 Global Healthcare Conference featuring Sensei Biotherapeutics (SNSE) be held?

The conference will be held in Miami, Florida.

What is Sensei Biotherapeutics' (SNSE) main focus as presented at the Citi Healthcare Conference?

Sensei Biotherapeutics is a clinical stage biotechnology company focused on discovering and developing next-generation therapeutics for cancer patients.

Which stock exchange is Sensei Biotherapeutics (SNSE) listed on?

Sensei Biotherapeutics is listed on the Nasdaq stock exchange under the ticker symbol SNSE.